Toward a chronotherapy of ovarian cancer with taxol. Part II: Test pilot study on circulating CA125.
Halberg
E
E
University of Minnesota, Minneapolis.
Long
H J
HJ
Cornélissen
G
G
Blank
M A
MA
Elg
S
S
Touitou
Y
Y
Bakken
E
E
Delmore
P
P
Haus
E
E
Sackett-Lundeen
L
L
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000276:immunology; D000368:Aged; D000470:Alkaloids / Q000008:administration & dosage*; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D002909:Chronobiology Phenomena; D002940:Circadian Rhythm / Q000502:physiology; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000276:immunology; D017239:Paclitaxel
D000470:Alkaloids; D015295:Antigens, Tumor-Associated, Carbohydrate; D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel